Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry
- PMID: 1549586
- PMCID: PMC48629
- DOI: 10.1073/pnas.89.6.2223
Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry
Abstract
Isolates of human immunodeficiency virus type 1 (HIV-1) undergo many different rates of replication, with the time course of replication being determined by the host cell and the virus. Recently, we demonstrated that the permissiveness of four CD4+ T-cell lines for the laboratory strain NL4-3 correlated with the rate and efficiency of virus entry. In this study, we have analyzed the replication of a "slow/low" isolate from the pre-AIDS period of infection and two "rapid/high" isolates from the AIDS period of infection to determine which steps in the virus life cycle determine differences in the growth characteristics of patient isolates. Differences in the growth of the patient isolates correlated with differences in entry but not postentry steps of the virus life cycle. The two rapid/high patient isolates (SF33 and SF216) underwent 50% entry in less than or equal to 0.5 hr in C8166 cells, in less than or equal to 1 hr in mitogen-stimulated peripheral blood mononuclear cells, and in greater than or equal to 2.5 hr in H9 cells. In contrast, a class 3 slow/low patient isolate required 1 hr for 50% entry into C8166 cells, 3 hr for 50% entry into peripheral blood mononuclear cells, and 5-6 hr for 50% entry into H9 cells. Entry efficiency correlated with entry rate, with the rapid/high viruses having a 2-fold higher titer and the slow/low virus having a 5-fold higher titer on C8166 than H9 cells. The laboratory strain NL4-3 displayed intermediate rates and efficiencies of entry. These data demonstrate that entry characteristics are major determinants of the pathogenic potential of patient isolates.
Similar articles
-
Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness.J Virol. 1991 Jul;65(7):3900-2. doi: 10.1128/JVI.65.7.3900-3902.1991. J Virol. 1991. PMID: 1674969 Free PMC article.
-
Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid.Virology. 1989 Nov;173(1):178-87. doi: 10.1016/0042-6822(89)90233-x. Virology. 1989. PMID: 2683359
-
Restricted replication of the HIV-1 T-lymphotropic isolate NL4-3 in HL-60 cells.Virology. 1995 Jan 10;206(1):641-5. doi: 10.1016/s0042-6822(95)80081-6. Virology. 1995. PMID: 7831819
-
Viral determinants of cellular tropism.Pathobiology. 1992;60(4):225-33. doi: 10.1159/000163727. Pathobiology. 1992. PMID: 1388720 Review.
-
Potential mechanisms for the cytopathic properties of HIV.AIDS. 1989 Nov;3(11):683-94. doi: 10.1097/00002030-198911000-00001. AIDS. 1989. PMID: 2575911 Review. No abstract available.
Cited by
-
Cell-to-Cell Spread of Retroviruses.Viruses. 2010 Jun;2(6):1306-1321. doi: 10.3390/v2061306. Epub 2010 Jun 10. Viruses. 2010. PMID: 21994681 Free PMC article.
-
HIV/AIDS Vaccines: 2018.Clin Pharmacol Ther. 2018 Dec;104(6):1062-1073. doi: 10.1002/cpt.1208. Epub 2018 Oct 9. Clin Pharmacol Ther. 2018. PMID: 30099743 Free PMC article. Review.
-
Selective transmission of R5 HIV-1 variants: where is the gatekeeper?J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S6. doi: 10.1186/1479-5876-9-S1-S6. J Transl Med. 2011. PMID: 21284905 Free PMC article. Review.
-
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.J Virol. 1995 Jan;69(1):101-9. doi: 10.1128/JVI.69.1.101-109.1995. J Virol. 1995. PMID: 7527081 Free PMC article.
-
EBV renders B cells susceptible to HIV-1 in humanized mice.Life Sci Alliance. 2020 Jun 23;3(8):e202000640. doi: 10.26508/lsa.202000640. Print 2020 Aug. Life Sci Alliance. 2020. PMID: 32576602 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials